Response of risperidone treatment may be associated with polymorphisms of HTT gene in chinese schizophrenia patientsLEI WANG; LAN YU; YUE XIAO et al.Neuroscience letters. 2007, Vol 414, Num 1, pp 1-4, issn 0304-3940, 4 p.Article

Risperidone for control of agitation in dementia patientsFALSETTI, A. E.American journal of health-system pharmacy. 2000, Vol 57, Num 9, pp 862-870, issn 1079-2082Article

Switching from therapy with typical antipsychotic agents to risperidone : Long-term impact on patient outcomeMALLA, A. K; NORMAN, R. M. G; KOTTEDA, V et al.Clinical therapeutics. 1999, Vol 21, Num 5, pp 806-817, issn 0149-2918Article

Risperidone-induced photosensitivityALMOND, D. S; RHODES, L. E; PIRMOHAMED, M et al.Postgraduate medical journal. 1998, Vol 74, Num 870, pp 252-253, issn 0032-5473Article

Syndrome malin des neuroleptiques induit par la rispéridone = Risperidone-induced neuroleptic malignant syndromeROHRBACH, P; COLLINOT, J. P; VALLET, G et al.Annales françaises d'anesthésie et de réanimation. 1998, Vol 17, Num 1, pp 85-86, issn 0750-7658Article

An open-label trial of Risperidone in children with autism : Trials in Pediatric PopulationsDILER, Rasim Somer; FIRAT, Sunay; AVCI, Ayse et al.Current therapeutic research. 2002, Vol 63, Num 1, pp 91-102, issn 0011-393XArticle

Clozapine-like motor effects of the atypical antipsychotic risperidone in ratsSTANFORD, J. A; FOWLER, S. C.Neuroscience letters. 2000, Vol 285, Num 3, pp 189-192, issn 0304-3940Article

A comparison of the relative safety, efficacy, and Tolerability of Quetiapine and risperidone in outpatients with schizophrenia and other psychotic disorders: The Quetiapine Experience with Safety and Tolerability (QUEST) studyMULLEN, Jamie; JIBSON, Michael D; SWEITZER, Dennis et al.Clinical therapeutics. 2001, Vol 23, Num 11, pp 1839-1854, issn 0149-2918Article

Neuroleptiques atypiques chez l'enfant et l'adolescent = Atypical neuroleptics in children and adolescentsNAJA, W. J; RENERIC, J. P; BOUVARD, M. P et al.L' Encéphale (Paris). 1998, Vol 24, Num 4, pp 378-385, issn 0013-7006Article

New antipsychotic medications : strategies for evaluation and selected findingsSCHOOLER, N. R.Schizophrenia research. 1997, Vol 27, Num 2-3, pp 249-259, issn 0920-9964Article

Risperidone in the elderly : A pharmacoepidemiologic studyZARATE, C. A; BALDESSARINI, R. J; SIEGEL, A. J et al.The Journal of clinical psychiatry. 1997, Vol 58, Num 7, pp 311-317, issn 0160-6689Article

Effects of switching inpatients with treatment-resistant schizophrenia from clozapine to risperidoneSTILL, D. J; DORSON, P. G; CRISMON, M. L et al.Psychiatric services (Washington, D.C.). 1996, Vol 47, Num 12, pp 1382-1384, issn 1075-2730Article

A pilot study on risperidone metabolism : The role of cytochromes P450 2D6 and 3ABORK, J. A; ROGERS, T; WEDLUND, P. J et al.The Journal of clinical psychiatry. 1999, Vol 60, Num 7, pp 469-476, issn 0160-6689Article

Novel antipsychotics and the Neuroleptic malignant syndrome : A review and critiqueHASAN, S; BUCKLEY, P.The American journal of psychiatry. 1998, Vol 155, Num 8, pp 1113-1116, issn 0002-953XArticle

Psychosis in medical conditions : Response to risperidoneFURMAGA, K. M; DELEON, O. A; SINHA, S. B et al.General hospital psychiatry. 1997, Vol 19, Num 3, pp 223-228, issn 0163-8343Article

Risperidone and explosive aggressive autismHORRIGAN, J. P; BARNHILL, L. J.Journal of autism and developmental disorders. 1997, Vol 27, Num 3, pp 313-323, issn 0162-3257Article

Use of novel antipsychotic drugsRALEIGH, F.Pharmacotherapy. 1996, Vol 16, Num 6, pp 160S-165S, issn 0277-0008, 2Article

SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEM DUE TO ORAL RISPERIDONEAKAY, Bengu Nisa; SANLI, Hatice.Pediatric dermatology. 2009, Vol 26, Num 2, pp 214-216, issn 0736-8046, 3 p.Article

Dopamine inhibition and the adaptation of behavior to ongoing realityPIHAN, Hans; GUTBROD, Klemens; BAAS, Ulrike et al.Neuroreport (Oxford). 2004, Vol 15, Num 4, pp 709-712, issn 0959-4965, 4 p.Article

Efficacy of atypical antipsychotics in mood disordersYATHAM, Lakshmi N.Journal of clinical psychopharmacology. 2003, Vol 23, Num 3, pp S9-S14, issn 0271-0749, SUP1Conference Paper

Diabète sous neuroleptiques = Diabetes under neuroleptic agentsLa Revue Prescrire. 2001, Vol 21, Num 223, issn 0247-7750, p. 834Article

A 52-year-old suicidal man, 1 year laterPARKER, Richard A; HARTMAN, Erin E.JAMA, the journal of the American Medical Association. 2001, Vol 285, Num 13, issn 0098-7484, p. 1757Article

Impact clinique des neuroleptiques atypiques : étude prospective sur 6 mois en milieu hospitalier de patients traités par rispéridone ou olanzapine = Clinical impact of atypical antipsychotics: prospective 6-month study of inpatients treated by risperidone or olanzapineHAMEL, B; COURTET, P; VERGNES, C et al.Thérapie (Paris). 2001, Vol 56, Num 6, pp 645-652, issn 0040-5957, 8 p.Article

La rispéridone est-elle responsable de manifestations respiratoires ? = Does resperidone cause respiratory manifestations ?TOURAINE, F; CLAVEL, M; GERICOT-PEAN, E et al.Revue des maladies respiratoires. 2000, Vol 17, Num 1, pp 117-118, issn 0761-8425Article

A naturalistic study of clinical use of risperidoneBINDER, R. L; MCNIEL, D. E; SANDBERG, D. A et al.Psychiatric services (Washington, D.C.). 1998, Vol 49, Num 4, pp 524-526, issn 1075-2730Article